pantethine has been researched along with Hypercholesterolemia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azumano, I; Citrolo, D; Evans, M; Kamiya, T; Napolitano, JJ; Rumberger, JA | 1 |
Arsenio, L; Caronna, S; Lateana, M; Magnati, G; Strata, A; Zammarchi, G | 1 |
Carrara, P; Franceschini, G; Galbussera, M; Lovati, MR; Matturri, L; Sirtori, CR | 1 |
Abiko, Y; Kameda, KY; Nakayasu, T; Tawara, K; Tomikawa, M | 1 |
Binaghi, P; Bruschi, F; Cellina, G; Lo Cicero, G; Penotti, M; Porcaro, E | 1 |
Balestreri, R; Bertolini, S; Cuzzolaro, S; Daga, A; Donati, C; Elicio, N; Marcenaro, A; Saturnino, M | 1 |
Graves, CP; Hansen, RG; Jorgensen, E; Peterson, MA; Thoene, JG; Wilson, DE; Windham, CT; Wittwer, CT; Wyse, BW | 1 |
1 trial(s) available for pantethine and Hypercholesterolemia
Article | Year |
---|---|
Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.
Topics: Adult; Anticholesteremic Agents; Biomarkers; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Female; Florida; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Ontario; Pantetheine; Patient Selection; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2014 |
6 other study(ies) available for pantethine and Hypercholesterolemia
Article | Year |
---|---|
[Hyperlipidemia, diabetes and atherosclerosis: efficacy of treatment with pantethine].
Topics: Adolescent; Adult; Aged; Apolipoproteins; Arteriosclerosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Complications; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pantetheine; Sulfhydryl Compounds | 1984 |
Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits.
Topics: Animals; Aorta, Abdominal; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Cholesterol, Dietary; Cholesterol, HDL; Coronary Vessels; Hypercholesterolemia; Isoelectric Focusing; Lipoproteins, HDL; Male; Pantetheine; Rabbits; Sulfhydryl Compounds | 1984 |
Effect of pantethine on lipoprotein profiles and HDL subfractions in experimentally hypercholesterolemic rabbits.
Topics: Animals; Cholesterol, Dietary; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Male; Pantetheine; Rabbits; Sulfhydryl Compounds | 1982 |
[Evaluation of the cholesterol-lowering effectiveness of pantethine in women in perimenopausal age].
Topics: Cholesterol, HDL; Cholesterol, LDL; Drug Evaluation; Female; Humans; Hypercholesterolemia; Menopause; Middle Aged; Pantetheine; Sulfhydryl Compounds; Triglycerides | 1990 |
Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children.
Topics: Adolescent; Adult; Aged; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Child; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; Pantetheine; Sulfhydryl Compounds; Triglycerides | 1986 |
Pantethine lipomodulation: evidence for cysteamine mediation in vitro and in vivo.
Topics: Animals; Cells, Cultured; Coenzyme A; Cysteamine; Diabetes Mellitus, Experimental; Humans; Hydrolysis; Hypercholesterolemia; Lipid Metabolism; Male; Pantetheine; Rabbits; Rats; Sulfhydryl Compounds | 1987 |